title: Operative treatment of early infection after internal fixation of limb fractures (exclusive of severe open fractures).
abstract: Early infection after open reduction and internal fixation (ORIF) of a limb bone is defined as bacteriologically documented, deep and/or superficial surgical-site infection (SSI) diagnosed within 6months after the surgical procedure. This interval is arbitrarily considered sufficient to obtain fracture healing. The treatment of early infection after ORIF should be decided by a multidisciplinary team. The principles are the same as for revision arthroplasty. Superficial SSIs should be differentiated from deep SSIs, based on the results of bacteriological specimens collected using flawless technique. A turning point in the local microbial ecology occurs around the third or fourth week, when a biofilm develops around metallic implants. This biofilm protects the bacteria. The treatment relies on both non-operative and operative measures, which are selected based on the time to occurrence of the infection, condition of the soft tissues, and stage of bone healing. Both the surgical strategy and the antibiotic regimen should be determined during a multidisciplinary discussion. When treating superficial SSIs after ORIF, soft-tissue management is the main challenge. The treatment differs according to whether the hardware is covered or exposed. Defects in the skin and/or fascia can be managed using reliable reconstructive surgery techniques, either immediately or after a brief period of vacuum-assisted closure. In deep SSIs, deciding whether to leave or to remove the hardware is difficult. If the hardware is removed, the fracture site can be stabilised provisionally using either external fixation or a cement rod. Once infection control is achieved, several measures can be taken to stimulate bone healing before the end of the classical 6-month interval. If the hardware was removed, then internal fixation must be performed once the infection is eradicated.
authors.affiliation: Département d'orthopédie traumatologie, CHU de Toulouse, hôpital P.P.-Riquet, place Baylac, 31052 Toulouse cedex, France. Electronic address: ventre.s@chu-toulouse.fr.
authors.forename: P
authors.initials: P
authors.lastname: Bonnevialle
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003661:Decision Support Techniques; D005264:Femoral Fractures / Q000601:surgery; D005593:Fracture Fixation, Internal / Q000009:adverse effects* / Q000379:methods; D017102:Fracture Healing; D050723:Fractures, Bone / Q000601:surgery*; D006801:Humans; D006810:Humeral Fractures / Q000601:surgery; D013530:Surgical Wound Infection / Q000188:drug therapy / Q000382:microbiology / Q000601:surgery*; D058106:Wound Closure Techniques
chemical_list: D000900:Anti-Bacterial Agents
keywords: Antibiotic therapy; Complications; Deep incisional surgical-site infection; Microbiological sampling; Multidisciplinary management; Nosocomial infection; ORIF for limb fractures; Superficial incisional surgical-site infection; Surgical-site infection